OPENING REMARKS

Navigating Public Health Priorities: Youth Protection and Effective Regulation

Benefits and risks of nicotine: Implications for public health

Tobacco Control in Asia: Taking Lessons from Regulation to Prohibition

An Update on Tobacco Control Bill in South Africa

The Illicit Trade Challenge: New Evidence, Regulatory Pressures and Policy Implications

Harm Reduction – What could Europe learn from the FDA?

Evidence-Informed Regulation: Integrating Science and Public Consultation into European Policy

What Are We Losing? The Health and Economic Price of Ignoring Scientific Evidence

Outrage Reduction about Harm Reduction: Addressing Public Health’s Anti-Noncombustibles Bias

ORAL PRESENTATIONS